One GLP-1 Drug May Be Better Than Rivals for Glaucoma Risk

(MedPage Today) — Use of the dual GIP/GLP-1 drug tirzepatide (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma compared with GLP-1 drugs among patients with type 2 diabetes, a large retrospective cohort study suggested…

Source link : https://www.medpagetoday.com/ophthalmology/glaucoma/118988

Author :

Publish date : 2025-12-13 13:00:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

One GLP-1 Drug May Be Better Than Rivals for Glaucoma Risk

Doctor strike during flu outbreak would be ‘beyond belief’, says Starmer

Florida Plows Ahead on Push to Roll Back Certain Vaccine Mandates for Schoolchildren

Related Posts

No Increased Breast Cancer Risk With Menopausal Estrogen in BRCA Carriers

How Were GLP-1 Drugs and Bone Health Linked?

Pain and Functioning; AI Decision Support for Stroke Treatment

Fragile Students Won’t Last in Medicine

Florida Plows Ahead on Push to Roll Back Certain Vaccine Mandates for Schoolchildren

Doctor strike during flu outbreak would be ‘beyond belief’, says Starmer

No Increased Breast Cancer Risk With Menopausal Estrogen in BRCA Carriers

How Were GLP-1 Drugs and Bone Health Linked?

Pain and Functioning; AI Decision Support for Stroke Treatment

Fragile Students Won’t Last in Medicine

Florida Plows Ahead on Push to Roll Back Certain Vaccine Mandates for Schoolchildren

One GLP-1 Drug May Be Better Than Rivals for Glaucoma Risk

Doctor strike during flu outbreak would be ‘beyond belief’, says Starmer

Why are sperm donors having hundreds of children?

Categories

Archives